NYSE:INSP - New York Stock Exchange, Inc. - US4577301090 - Common Stock - Currency: USD
INSPIRE MEDICAL SYSTEMS INC
NYSE:INSP (1/24/2025, 5:05:00 PM)
After market: 188.47 0 (0%)188.47
+0.88 (+0.47%)
The current stock price of INSP is 188.47 USD. In the past month the price increased by 0.47%. In the past year, price decreased by -11.44%.
Inspire Reports Year-over-Year Revenue Growth of 25% for the Fourth Quarter and 28% for the Full Year 2024...
Inspire Medical, which makes innovative apnea relief devices, hit a key performance benchmark as its Relative Strength Rating jumped to 81.
MINNEAPOLIS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter...
MINNEAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 26.77 | 216.86B | ||
ISRG | INTUITIVE SURGICAL INC | 79.68 | 208.03B | ||
SYK | STRYKER CORP | 33.88 | 150.32B | ||
BSX | BOSTON SCIENTIFIC CORP | 43.19 | 150.24B | ||
MDT | MEDTRONIC PLC | 17.18 | 115.65B | ||
BDX | BECTON DICKINSON AND CO | 18.5 | 70.60B | ||
EW | EDWARDS LIFESCIENCES CORP | 25.84 | 40.69B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 21.01 | 40.51B | ||
RMD | RESMED INC | 30.22 | 36.77B | ||
IDXX | IDEXX LABORATORIES INC | 39.76 | 35.64B | ||
DXCM | DEXCOM INC | 52.21 | 34.67B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 20.05 | 25.26B |
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 1,011 full-time employees. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
INSPIRE MEDICAL SYSTEMS INC
5500 Wayzata Blvd Ste 1600
Golden Valley MINNESOTA 55416 US
CEO: TimothyP. Herbert
Employees: 1011
Company Website: https://www.inspiresleep.com/
Investor Relations: https://investors.inspiresleep.com/
Phone: 17639575037
The current stock price of INSP is 188.47 USD.
The exchange symbol of INSPIRE MEDICAL SYSTEMS INC is INSP and it is listed on the New York Stock Exchange, Inc. exchange.
INSP stock is listed on the New York Stock Exchange, Inc. exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for INSP, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of INSP.
INSP does not pay a dividend.
INSP will report earnings on 2025-02-10, after the market close.
The PE ratio for INSP is 176.14. This is based on the reported non-GAAP earnings per share of 1.07 and the current share price of 188.47 USD.
The outstanding short interest for INSP is 8.07% of its float.
ChartMill assigns a technical rating of 2 / 10 to INSP. When comparing the yearly performance of all stocks, INSP is a bad performer in the overall market: 77.07% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to INSP. While INSP has a great health rating, its profitability is only average at the moment.
Over the last trailing twelve months INSP reported a non-GAAP Earnings per Share(EPS) of 1.07. The EPS increased by 194.69% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.37% | ||
ROA | 4.15% | ||
ROE | 4.74% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 79% to INSP. The Buy consensus is the average rating of analysts ratings from 25 analysts.
For the next year, analysts expect an EPS growth of 282.55% and a revenue growth 28.5% for INSP